mRNA/Biomarker Quantification and Statistical Analysis

Creative Bioarray's RNA ISH assay enables the visualization and quantification of mRNA presence and biomarker expression in processed tissue samples. We specialize in providing mRNA/biomarker quantification and statistical analysis services in a manner that is both high-quality and cost-effective. Our service can significantly expedite and validate the progression of your gene therapy developments.

In the world of biomedical research, mRNA and biomarker quantitative detection play pivotal roles, particularly in the realm of mRNA vaccine development. The application of these methods allows researchers to delve into the finer details of the mRNA vaccines, inspecting their genetic responses at the molecular level. This provides definitive insights that can assist in optimizing vaccine efficiency and mitigating potential risks.

Benefits of mRNA/Biomarker Quantification and Statistical Analysis

(1) mRNA+ cell detection and quantification in intact fixed tissue
(2) Quantifiable assays to measure percentage of cells positive for mRNA and biomarker expression

Quotation and ordering

Our customer service representatives are available 24hr a day! We thank you for considering Creative Bioarray as your mRNA/ASO/Biomarker Quantification and Statistical Analysis partner.

References

1. Kole, R.; Krainer, A.R.; Altman, S. RNA therapeutics: Beyond RNA interference and antisense oligonucleotides. Nat. Rev. Drug Discov. 2012, 11, 125–140.
2. Aagaard, L.; Rossi, J.J. RNAi therapeutics: Principles, prospects and challenges. Adv. Drug Deliv. Rev. 2007, 59, 75–86.
3. Goto, Akihiko, Syunsuke Yamamoto, and Shinji Iwasaki. "Biodistribution and delivery of oligonucleotide therapeutics to the central nervous system: Advances, challenges, and future perspectives." Biopharmaceutics & Drug Disposition 44.1 (2023): 26-47.